ACES Diagnostics
Paradise Valley, US · Founded 2024 · Delaware corporation
Aces Diagnostics is developing LYMESEEK, an AI-driven blood test for detecting Lyme disease across all stages of the disease, aimed at physicians and clinical laboratories. The single blood-draw test runs on existing lab equipment and is being validated on clinical samples in the U.S. and E.U., with commercial launch anticipated in 2027.
Founders & leadership
ACES Diagnostics was founded in 2024 by Monica Embers, Holly Ahern, and Todd Snowden.
ME

Monica EmbersinFounder & Chief Research Officer
HA

Holly AherninFounder & Chief Scientific Officer
TS

Todd SnowdeninFounder & Chief Commercial OfficerTodd Snowden brings 35+ years of experience in medical device, diagnostics, and laboratory services, including roles in product management, sales leadership, and chief executive positions at startup and mid-size firms. His background spans regulatory strategy, commercialization, and international business development across the U.S., Europe, and Latin America.
TC

Tammy CrawfordinChief Executive Officer
LS
Lisa StoneChief Financial Officer
JK
Jim KirkChief Development Officer
PS

Phillip StaffordinChief Data Officer
Reported raises · per SEC filings
Form D private placements$4M disclosed across 2 rounds · 2024–2026
▶$400KraisedJun 2026 · 2 investors · OtherRule 506(b)
▶$400KraisedJun 2026 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tammy CrawfordExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $400K
- Minimum investment
- $25K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$3.6MraisedJun 2026 · 27 investors · OtherRule 506(b)
▶$3.6MraisedJun 2026 · 27 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tammy CrawfordExecutive Officer, Director
- Offering amount
- $3.6M
- Amount sold
- $3.6M
- Minimum investment
- $25K
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapQuest Diagnostics8 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Labcorp5 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Rupa Health4 shared keywordsA platform that enables healthcare providers to order, track, and receive lab test results from multiple laboratory companies through a single dashboard, supporting both in-person and telehealth patients with flexible billing options and EHR integration.
Medscape3 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies competing with ACES Diagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does ACES Diagnostics do?
- Aces Diagnostics is developing LYMESEEK, an AI-driven blood test for detecting Lyme disease across all stages of the disease, aimed at physicians and clinical laboratories. The single blood-draw test runs on existing lab equipment and is being validated on clinical samples in the U.S. and E.U., with commercial launch anticipated in 2027.
- Who founded ACES Diagnostics?
- ACES Diagnostics was founded by Monica Embers, Holly Ahern, Todd Snowden in 2024.
- How much funding has ACES Diagnostics raised?
- ACES Diagnostics has disclosed $4M raised across 2 rounds.
- Where is ACES Diagnostics headquartered?
- ACES Diagnostics is headquartered in Paradise Valley, US.

